DK4049290T3 - Systemer og fremgangsmåder til design af vacciner - Google Patents

Systemer og fremgangsmåder til design af vacciner

Info

Publication number
DK4049290T3
DK4049290T3 DK20807202.5T DK20807202T DK4049290T3 DK 4049290 T3 DK4049290 T3 DK 4049290T3 DK 20807202 T DK20807202 T DK 20807202T DK 4049290 T3 DK4049290 T3 DK 4049290T3
Authority
DK
Denmark
Prior art keywords
systems
methods
vaccine design
vaccine
design
Prior art date
Application number
DK20807202.5T
Other languages
English (en)
Inventor
Armaghan Waseem Naik
Mario Barro
Original Assignee
Sanofi Pasteur Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur Inc filed Critical Sanofi Pasteur Inc
Application granted granted Critical
Publication of DK4049290T3 publication Critical patent/DK4049290T3/da

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/70ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for mining of medical data, e.g. analysing previous cases of other patients
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B30/00ICT specially adapted for sequence analysis involving nucleotides or amino acids
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B5/00ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
    • G16B5/30Dynamic-time models
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/20ICT specially adapted for the handling or processing of patient-related medical or healthcare data for electronic clinical trials or questionnaires
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/80ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for detecting, monitoring or modelling epidemics or pandemics, e.g. flu
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/40ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00ICT specially adapted for the handling or processing of medical references
    • G16H70/60ICT specially adapted for the handling or processing of medical references relating to pathologies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Data Mining & Analysis (AREA)
  • Biomedical Technology (AREA)
  • Databases & Information Systems (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Theoretical Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Evolutionary Biology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Chemical & Material Sciences (AREA)
  • Artificial Intelligence (AREA)
  • Evolutionary Computation (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Software Systems (AREA)
  • Bioethics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DK20807202.5T 2019-10-21 2020-10-20 Systemer og fremgangsmåder til design af vacciner DK4049290T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962924096P 2019-10-21 2019-10-21
PCT/US2020/056507 WO2021080990A1 (en) 2019-10-21 2020-10-20 Systems and methods for designing vaccines

Publications (1)

Publication Number Publication Date
DK4049290T3 true DK4049290T3 (da) 2025-12-08

Family

ID=73402160

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20807202.5T DK4049290T3 (da) 2019-10-21 2020-10-20 Systemer og fremgangsmåder til design af vacciner

Country Status (6)

Country Link
US (2) US12354756B2 (da)
EP (2) EP4635511A3 (da)
JP (2) JP7801214B2 (da)
CN (1) CN114830259A (da)
DK (1) DK4049290T3 (da)
WO (1) WO2021080990A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11771652B2 (en) 2020-11-06 2023-10-03 Sanofi Lipid nanoparticles for delivering mRNA vaccines
WO2022264109A1 (en) 2021-06-18 2022-12-22 Sanofi Multivalent influenza vaccines
AU2022361432A1 (en) 2021-10-08 2024-05-23 Sanofi Pasteur Inc. Multivalent influenza vaccines
CA3237139A1 (en) 2021-11-05 2023-05-11 Sanofi Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
CA3237134A1 (en) 2021-11-05 2023-05-11 Timothy ALEFANTIS Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
WO2024042430A1 (en) * 2022-08-22 2024-02-29 Pfizer Inc. Computerized decision tool for sars-cov-2 variants prediction
WO2024126809A1 (en) 2022-12-15 2024-06-20 Sanofi Mrna encoding influenza virus-like particle
WO2025216910A1 (en) * 2024-04-08 2025-10-16 Sanofi Pasteur, Inc. Selecting a candidate antigen for a vaccine using a biological response machine learning model
WO2025216911A1 (en) * 2024-04-08 2025-10-16 Sanofi Pasteur, Inc. Selecting a candidate antigen for a vaccine using a biological response machine learning model

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8452541B2 (en) * 2007-06-18 2013-05-28 Microsoft Corporation Vaccine design methodology
WO2012112534A2 (en) 2011-02-14 2012-08-23 Carnegie Mellon University Learning to predict effects of compounds on targets
CN109448781B (zh) 2018-11-06 2021-09-14 云南大学 一种流感病毒抗原变化的预测方法

Also Published As

Publication number Publication date
JP2025060935A (ja) 2025-04-10
EP4635511A2 (en) 2025-10-22
WO2021080990A1 (en) 2021-04-29
JP7801214B2 (ja) 2026-01-16
EP4049290B1 (en) 2025-08-27
US20210118575A1 (en) 2021-04-22
JP2022552745A (ja) 2022-12-19
CN114830259A (zh) 2022-07-29
EP4049290A1 (en) 2022-08-31
US12354756B2 (en) 2025-07-08
EP4635511A3 (en) 2026-01-14
US20250308710A1 (en) 2025-10-02

Similar Documents

Publication Publication Date Title
DK3577446T3 (da) Systemer og fremgangsmåder til registrering af skade
DK3727240T4 (da) Hjælpeanordninger til et stomisystem og tilhørende fremgangsmåder til kommunikering af funktionstilstand
DK3398022T3 (da) Systemer og fremgangsmåder til tilpasning af uav-bane
DK3270944T3 (da) Optimerede leverspecifikke ekspressionssystemer til FVIII og FIX
DK3259386T3 (da) Systemer og fremgangsmåder til udførelse af immunoassays
DK3436339T3 (da) Fremgangsmåde og system til drift af én eller flere bugserbåde
DK3265947T3 (da) Fremgangsmåde og system til kryptering
DK3129912T3 (da) Fremgangsmåde og system til sikring af data
DK3346629T3 (da) Fremgangsmåde og enhed til overførsel af informationer
DK3328285T3 (da) Fremgangsmåde og system til korrigering af fedt-inducerede aberrationer
DK4054200T3 (da) Systemer og fremgangsmåder til indstilling af bufferstørrelse
DK3243251T3 (da) Systemer og fremgangsmåder til aktivering af et blokeringssystem med transformer-neutralpunkt
DK4434585T3 (da) Forbindelser og fremgangsmåder til reduktion af snca-ekspression
DK3280441T3 (da) Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf
DK3676561T3 (da) Systemer og fremgangsmåder til påføring af markeringer
DK3436338T3 (da) Fremgangsmåde og system til drift af én eller flere bugserbåde
DK3405026T3 (da) Systemer og fremgangsmåder til overførsel af æg
DK4428234T3 (da) Direkte-til-bibliotek-fremgangsmåder, systemer og sammensætninger
DK3692009T3 (da) Biocementationsfremgangsmåde og system
DK3441381T3 (da) Fremgangsmåde til fremstilling af methanol og indretning til fremstilling af methanol
IL286223A (en) Microbolometer systems and methods
DK3665081T3 (da) System til håndtering af bagage og fremgangsmåde til håndtering af bagage
DK3841066T3 (da) Afsaltningssystem og fremgangsmåde
DK3727623T3 (da) Legesystem og fremgangsmåde til detektering af legetøjselementer
DK3665106T3 (da) Indretning og fremgangsmåde til håndtering af stænger